TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 148 filers reported holding TRANSLATE BIO INC in Q2 2021. The put-call ratio across all filers is 1.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $290,000 | +57.6% | 10,536 | -5.6% | 0.12% | +52.6% |
Q1 2021 | $184,000 | -8.9% | 11,160 | +1.8% | 0.08% | -7.1% |
Q4 2020 | $202,000 | -27.9% | 10,959 | -46.8% | 0.08% | -42.9% |
Q3 2020 | $280,000 | -33.2% | 20,599 | -12.0% | 0.15% | -25.8% |
Q2 2020 | $419,000 | +1.0% | 23,395 | -43.8% | 0.20% | +15.8% |
Q1 2020 | $415,000 | +7.0% | 41,612 | -12.7% | 0.17% | +171.4% |
Q4 2019 | $388,000 | – | 47,685 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Advisors, Inc. | 2,656,517 | $48,960,000 | 10.98% |
Copernicus Capital Management, LLC | 12,091 | $223,000 | 3.48% |
FRAZIER MANAGEMENT LLC | 2,182,789 | $40,229,000 | 3.10% |
Baupost Group | 18,044,239 | $326,236,000 | 3.01% |
DAFNA Capital Management LLC | 225,393 | $4,154,000 | 1.24% |
RTW INVESTMENTS, LP | 2,978,427 | $54,892,000 | 0.92% |
MARATHON CAPITAL MANAGEMENT | 143,275 | $2,640,000 | 0.78% |
Bain Capital Public Equity Management II, LLC | 627,387 | $11,563,000 | 0.59% |
Artal Group S.A. | 1,200,000 | $22,116,000 | 0.48% |
Birchview Capital, LP | 30,000 | $553,000 | 0.32% |